• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价与荟萃分析:进行性家族性肝内胆汁淤积症中的部分外引流术

Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.

作者信息

Verkade Henkjan J, Thompson Richard J, Arnell Henrik, Fischler Björn, Gillberg Per-Göran, Mattsson Jan P, Torfgård Kristina, Lindström Erik

机构信息

Department of Pediatrics, University of Groningen, Beatrix Children's Hospital/University Medical Center Groningen, Groningen, The Netherlands.

Institute of Liver Studies, King's College London, London, United Kingdom.

出版信息

J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):176-183. doi: 10.1097/MPG.0000000000002789.

DOI:10.1097/MPG.0000000000002789
PMID:32433433
Abstract

OBJECTIVES

We assessed available data on impact of partial external biliary diversion (PEBD) surgery on clinical outcomes in patients with progressive familial intrahepatic cholestasis (PFIC).

METHODS

We performed a systematic literature review (PubMed) and meta-analysis to evaluate relationships between liver biochemistry parameters (serum bile acids, bilirubin, and alanine aminotransferase [ALT]) and early response (pruritus improvement) or long-term outcomes (need for liver transplant) in patients with PFIC who underwent PEBD.

RESULTS

Searches identified 175 publications before September 2018; 16 met inclusion criteria. Receiver operating characteristic (ROC) analysis examined ability of liver biochemistry parameters to discriminate patients who demonstrated early and long-term response to PEBD from those who did not. Regarding pruritus improvement in 155 included patients in aggregate, 104 (67%) were responders, 14 (9%) had partial response, and 37 (24%) were nonresponders. In ROC analyses of individual patient data, post-PEBD serum concentration of bile acids, in particular, could discriminate responders from nonresponders for pruritus improvement (area under the curve, 0.99; P < 0.0001; n = 42); to a lesser extent, this was also true for bilirubin (0.87; P = 0.003; n = 31), whereas ALT could not discriminate responders from nonresponders for pruritus improvement (0.74; P = 0.06; n = 28). Reductions from pre-PEBD values in serum bile acid concentration (0.89; P = 0.0003; n = 32) and bilirubin (0.98; P = 0.002; n = 18) but not ALT (0.62; P = 0.46; n = 18) significantly discriminated decreased aggregate need for liver transplant.

CONCLUSION

Changes in bile acids seem particularly useful in discriminating early and long-term post-PEBD outcomes and may be potential biomarkers of response to interruption of enterohepatic circulation in patients with PFIC.

摘要

目的

我们评估了部分体外胆汁转流术(PEBD)对进行性家族性肝内胆汁淤积症(PFIC)患者临床结局影响的现有数据。

方法

我们进行了一项系统的文献综述(PubMed)和荟萃分析,以评估接受PEBD的PFIC患者的肝脏生化参数(血清胆汁酸、胆红素和丙氨酸转氨酶[ALT])与早期反应(瘙痒改善)或长期结局(肝移植需求)之间的关系。

结果

检索在2018年9月之前共识别出175篇出版物;16篇符合纳入标准。受试者工作特征(ROC)分析检查了肝脏生化参数区分对PEBD有早期和长期反应的患者与无反应患者的能力。关于总共155例纳入患者的瘙痒改善情况,104例(67%)有反应,14例(9%)有部分反应,37例(24%)无反应。在个体患者数据的ROC分析中,尤其是PEBD术后胆汁酸血清浓度能够区分瘙痒改善的有反应者与无反应者(曲线下面积,0.99;P<0.0001;n=42);胆红素在较小程度上也如此(0.87;P=0.003;n=31),而ALT不能区分瘙痒改善的有反应者与无反应者(0.74;P=0.06;n=28)。血清胆汁酸浓度(0.89;P=0.0003;n=32)和胆红素(0.98;P=0.002;n=18)相对于PEBD术前值的降低显著区分了肝移植总需求的减少,但ALT(0.62;P=0.46;n=18)没有。

结论

胆汁酸变化似乎对区分PEBD术后早期和长期结局特别有用,可能是PFIC患者对肠肝循环中断反应的潜在生物标志物。

相似文献

1
Systematic Review and Meta-analysis: Partial External Biliary Diversion in Progressive Familial Intrahepatic Cholestasis.系统评价与荟萃分析:进行性家族性肝内胆汁淤积症中的部分外引流术
J Pediatr Gastroenterol Nutr. 2020 Aug;71(2):176-183. doi: 10.1097/MPG.0000000000002789.
2
Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis.血清胆汁酸正常化表明部分外引流术对进行性家族性肝内胆汁淤积症患儿有极好的长期疗效。
J Pediatr Surg. 2012 Mar;47(3):501-5. doi: 10.1016/j.jpedsurg.2011.08.010.
3
Biliary diversion in progressive familial intrahepatic cholestasis: a systematic review and meta-analysis.进行性家族性肝内胆汁淤积症的胆分流术:系统评价和荟萃分析。
Expert Rev Gastroenterol Hepatol. 2022 Feb;16(2):163-172. doi: 10.1080/17474124.2022.2032660. Epub 2022 Feb 15.
4
Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.针对进行性家族性肝内胆汁淤积症的胆汁转流术:改善肝脏形态及胆汁酸谱。
Gastroenterology. 2003 Oct;125(4):1227-34. doi: 10.1016/s0016-5085(03)01199-5.
5
Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.进行性家族性肝内胆汁淤积症和阿拉吉尔综合征患儿的部分外引流术
J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):216-21. doi: 10.1097/MPG.0b013e31819a4e3d.
6
Influence of Partial External Biliary Diversion on the Lipid Profile in Children With Progressive Familial Intrahepatic Cholestasis.部分外引流术对进行性家族性肝内胆汁淤积症患儿血脂的影响
J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):598-602. doi: 10.1097/MPG.0000000000001185.
7
Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases.部分外引流术治疗进行性家族性肝内胆汁淤积症患儿顽固性瘙痒:2例报告
Surg Today. 2008;38(8):726-30. doi: 10.1007/s00595-007-3736-9. Epub 2008 Jul 31.
8
A Report of 2 Infant Siblings with Progressive Intrahepatic Familial Cholestasis Type 1 and a Novel Homozygous Mutation in the ATP8B1 Gene Treated with Partial External Biliary Diversion and Liver Transplant.2 例婴儿同胞兄妹进行性肝内家族性胆汁淤积症 1 型伴 ATP8B1 基因纯合新突变的报告:部分外引流和肝移植治疗。
Am J Case Rep. 2021 Jul 20;22:e932374. doi: 10.12659/AJCR.932374.
9
Ileal exclusion in children with progressive familial intrahepatic cholestasis.儿童进行回肠旁路术以治疗进行性家族性肝内胆汁淤积症。
J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):92-5. doi: 10.1097/MPG.0b013e3182a9097c.
10
Clinical Variability After Partial External Biliary Diversion in Familial Intrahepatic Cholestasis 1 Deficiency.家族性肝内胆汁淤积症1型缺陷患者行部分外引流术后的临床变异性
J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):425-430. doi: 10.1097/MPG.0000000000001493.

引用本文的文献

1
Progressive familial intrahepatic cholestasis type 4: a case report.进行性家族性肝内胆汁淤积症 4 型:病例报告。
J Med Case Rep. 2024 Sep 7;18(1):434. doi: 10.1186/s13256-024-04662-5.
2
Odevixibat: A Novel Bile Salt Inhibitor Treatment for Pruritus in Progressive Familial Intrahepatic Cholestasis.奥地维西巴特:一种用于治疗进行性家族性肝内胆汁淤积症瘙痒的新型胆盐抑制剂疗法。
Cureus. 2024 Mar 25;16(3):e56886. doi: 10.7759/cureus.56886. eCollection 2024 Mar.
3
Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis.
关于进行性家族性肝内胆汁淤积症诊断与治疗的意见书
JHEP Rep. 2023 Oct 27;6(1):100949. doi: 10.1016/j.jhepr.2023.100949. eCollection 2024 Jan.
4
Evaluation of Clinical Outcomes in Children with Intrahepatic Cholestasis Postpartial External Biliary Diversion: A Single-Center Experience.部分体外胆汁转流术后肝内胆汁淤积患儿的临床结局评估:单中心经验
J Indian Assoc Pediatr Surg. 2023 Jul-Aug;28(4):293-299. doi: 10.4103/jiaps.jiaps_49_23. Epub 2023 Jul 11.
5
Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center.进行性家族性肝内胆汁淤积症:在一家三级医疗中心的描述性研究。
Int J Hepatol. 2023 Jul 20;2023:1960152. doi: 10.1155/2023/1960152. eCollection 2023.
6
Dental management of a pediatric patient with progressive familial intrahepatic cholestasis having dental anomalies: a case report and brief review of the literature.患有进行性家族性肝内胆汁淤积症和牙齿异常的儿科患者的口腔管理:病例报告及文献复习。
BMC Oral Health. 2023 Jan 9;23(1):10. doi: 10.1186/s12903-022-02593-5.
7
Internal Ileal Diversion as Treatment for Progressive Familial Intrahepatic Cholestasis Type 1-Associated Graft Inflammation and Steatosis after Liver Transplantation.回肠内转流术治疗1型进行性家族性肝内胆汁淤积症相关的肝移植术后移植物炎症和脂肪变性
Children (Basel). 2022 Dec 14;9(12):1964. doi: 10.3390/children9121964.
8
Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis.奥贝胆酸:进行性家族性肝内胆汁淤积症的有前途的新治疗方法。
Expert Opin Pharmacother. 2022 Nov;23(16):1771-1779. doi: 10.1080/14656566.2022.2140040. Epub 2022 Oct 30.
9
Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies.1型、2型和3型进行性家族性肝内胆汁淤积症的最新进展:预后及治疗策略
World J Hepatol. 2022 Jan 27;14(1):98-118. doi: 10.4254/wjh.v14.i1.98.
10
Newer variants of progressive familial intrahepatic cholestasis.进行性家族性肝内胆汁淤积症的新型变异体
World J Hepatol. 2021 Dec 27;13(12):2024-2038. doi: 10.4254/wjh.v13.i12.2024.